Company News
Piramal & NP2 Complete Cyclophosphamide Development Oct
Piramal Pharma Solutions and nonprofit NP2 will finish development of generic injectable cyclophosphamide at Lexington, Kentucky in October 2026.
$85 million Lexington expansion will boost cyclophosph
